CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of IoGen™ for the Treatment of Moderate or Severe, Periodic Breast Pain Associated With Symptomatic Fibrocystic Breast Disease

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00237523
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:34:51.252769+00:00
Published At: 2007-06-18T00:00:00+00:00
Record Updated At: 2007-06-18
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Fibrocystic Disease of Breast", "Fibrocystic Changes of Breast", "Fibrocystic Mastopathy", "Pain"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2007-06-18"
protocolSection.identificationModule.nctId: "NCT00237523"
protocolSection.identificationModule.officialTitle: "A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of IoGen\u2122 for the Treatment of Moderate or Severe, Periodic Breast Pain Associated With Symptomatic Fibrocystic Breast Disease"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.